• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconDaraprim

Daraprim

Page 2 of 2
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Health
Valeant under federal investigation for how it prices drugs
By Laura LorenzettiOctober 15, 2015
The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
Health
The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
By Laura LorenzettiSeptember 29, 2015
MSMB Capital Management CIO Martin Shkreli
Health
Record label cuts ties with besieged pharma CEO Martin Shkreli
By Daniel RobertsSeptember 25, 2015
GOP Candidate For President Donald Trump Campaigns In Columbia, South Carolina
Leadership
Donald Trump on drug price-raising CEO: ‘Spoiled brat’
By Laura LorenzettiSeptember 24, 2015
MSMB Capital Management CIO Martin Shkreli
Health
Turing backs down on Daraprim drug pricing
By TIMESeptember 23, 2015
157934085
Health
Doctors respond to Turing drug price hike: ‘It’s scare mongering’
By Laura LorenzettiSeptember 22, 2015
MSMB Capital Management CIO Martin Shkreli
Health
Here’s why Turing Pharmaceuticals says 5,000% price bump is necessary
By Laura LorenzettiSeptember 21, 2015
Picture taken on January 15, 2012 in Lil
Health
This 62-year-old drug just got 5,000% more expensive
By Laura LorenzettiSeptember 21, 2015
1
  • 1
  • 2
2
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Newsletters
The Supreme Court's birthright citizenship ruling hands the U.S. economy a $7.7 trillion winplaceholder alt text
By Diane BradyJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.